T hank you very much for the opportunity to add results for normal-weight women in our study population. We agree that these data are important for the current discussion of the risk of type 2 diabetes (T2D) in normal-weight women with polycystic ovary syndrome (PCOS) (1, 2). In addition, we present data for waist circumference $88 cm as an indicator for central obesity, confirming it as an important predictor of insulin resistance in our PCOS cohort (3).
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Additional Results for PCOS Odense University Hospital
Baseline body mass index (BMI) ,25 kg/m 2 and later development of T2D was observed in 12 of 1082 (1%) women in PCOS Odense University Hospital (OUH), whereas 99 of 1082 (9%) with baseline BMI $25 kg/m 2 developed T2D ( Table 1 ). The odds ratio was 6.61 (95% confidence interval, 3.22 to 13.58; P , 0.001) for development of T2D in women with PCOS and BMI $25 kg/m 2 vs women with PCOS and BMI ,25 kg/m 2 . Baseline waist circumference ,88 cm and later development of T2D was observed in 9 of 729 (1%) women in PCOS OUH, whereas 56 of 729 (8%) with baseline waist circumference $88 cm developed T2D. The odds ratio was 6.24 (95% confidence interval, 3.38 to 11.50; P , 0.001) for development of T2D in women with PCOS and waist circumference $88 cm vs women with PCOS and waist circumference ,88 cm.
PCOS OUH vs Controls
The hazard ratio was 1.22 (95% confidence interval, 0.58 to 2.55; P 5 0.60) for development of T2D in lean (BMI ,25 kg/m 2 ) women with PCOS vs age-matched controls. The hazard ratio was 6.57 (95% confidence interval, 4.53 to 9.54; P , 0.001) for development of T2D in women with PCOS and BMI $25 kg/m 2 vs agematched controls.
Discussion
Our data support a low risk for development of T2D in normal-weight women with PCOS, and the risk for developing T2D in lean women with PCOS was comparable to that of age-matched controls. Our data are supported by the articles mentioned in the letter by Livadas. We wonder whether the table provided by Livadas should also include the study by Ollila et al. (1) regarding results from oral glucose tolerance tests in a Finnish study population. Furthermore, we have an article in press regarding the outcome of oral glucose tolerance tests in a Nordic study population of women with PCOS (4). We performed oral glucose tolerance tests in 876 Nordic women with PCOS, aged 14 to 57 years, and found that no woman with BMI ,25 kg/m 2 had a diagnosis of T2D (4) . Taken together, the available results indicate that lean women with PCOS may not need prospective screening for T2D during follow-up. 
